Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01

Authors:

Abstract
No abstract available

This publication has 34 references indexed in Scilit: